Intrinsic Value

The intrinsic value of Athanase Innovation AB (H6H) under the Base Case is 1.77 EUR per share. Compared with the current market price of 1.77 EUR, the stock appears Fairly Valued .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

H6H Intrinsic Value
€1.77
Fairly Valued
Intrinsic Value
Price €1.77

H6H is more expensive than usual. Its valuation was this high or higher on just 10% of days in the past 4 years.

Monitor H6H
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €1.42
Get notified when the price drops into your buy zone
Intrinsic Value €1.77
Current Price €1.77
Margin of Safety 20% €1.42
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to H6H

Fundamental Analysis

What Athanase Innovation AB Does

Financial Services Financials

Athanase Innovation is an investment company, not an operating business. It raises capital from its shareholders and uses that money to buy and hold stakes in technology and software companies, usually businesses with recurring revenue and long growth runways. Its job is to pick these holdings, support them as an owner, and build a portfolio of innovation-focused assets over time.

Headquarters
Sweden SE
IPO date
May 8, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Athanase Innovation AB

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one H6H stock?

The intrinsic value for Athanase Innovation AB (H6H) under the Base Case is 1.77 EUR.

Is H6H stock undervalued or overvalued?

Compared with the current market price of 1.77 EUR, the stock appears Fairly Valued .

Back to Top